글로벌 스마트 바이옵시 장비 시장 – 2029년까지의 산업 동향 및 예측

스마트 바이옵시 장비 시장의 시장 분석 및 통찰력

Data Bridge Market Research는 스마트 바이옵시 장치 시장이 2022-2029년 예측 기간 동안 약 6.12%의 CAGR을 보일 것이라고 분석했습니다. 최소 침습 수술 절차에 대한 수요 증가, 의료 기기와 관련된 연구 개발 능력에 대한 집중 증가, 첨단 IT 의료 기술 도입 , 전 세계적으로 증가하는 암 사례, 특히 개발 도상국의 의료 인프라 개발에 대한 지출 증가 가 스마트 바이옵시 장치 시장 성장에 기여하는 주요 요인입니다.

생검은 환자의 암에 사용되는 의료 검사입니다. 생검은 검사 및 진단 목적으로 조직의 외과적 추출을 포함합니다. 스마트 생검 장치는 건강한 세포와 ​​종양 세포의 고품질 분화를 용이하게 하는 의료 장치입니다.  

목표 연구 활동을 위한 공공-민간 자금 지원의 급증   과 스마트 생체 검사 기기가 제공하는 이점에 대한 인식 증가는 시장 성장을 촉진하는 주요 요인 중 하나입니다. 로봇 분야에서 증가하는 기술적 진보와 개발은 또 다른 시장 성장 결정 요인입니다. 새로운 의료 기기 및 기구의 끊임없이 증가하는 기술적 진보와 혁신, 제품 출시 수의 증가, 연구 활동에 대한 정부의 지원 증가, 유방암 유병률 급증, 개인의 건강에 해로운 생활 방식, 여성의 자궁 경부암 사례 증가, 정부 자금 지원 증가 및 신흥 시장의 미개척 잠재력은 수익성 있는 시장 성장 기회를 더욱 창출할 것입니다.

However, high costs associated with biopsy medical test and lack of skilled medical professionals will derail the market growth rate. Also, lack of awareness in the underdeveloped and backward economies and high expenditure required for research and development activities will further pose challenges for the market. High risk of infection and rising number of product recalls will further derail the market growth rate.

This smart biopsy devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on smart biopsy devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Smart Biopsy Devices Market Scope and Market Size

The smart biopsy devices market is segmented on the basis of application, product, guidance technique and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• Based on application, the smart biopsy devices market is segmented into breast cancer, skin cancer, liver cancer, prostate cancer, and others.
• On the basis of product, the smart biopsy devices market is segmented into needle-based biopsy instruments, procedure trays, localization wires, and other products. Needle-based biopsy instruments are further segmented into core biopsy devices, aspiration biopsy needles, vacuum-assisted biopsy devices, localization wires, procedure trays, and others. Core biopsy devices are further sub-segmented into core biopsy guns and core biopsy needles. Vacuum-assisted biopsy devices are further sub-segmented into vacuum-assisted biopsy systems and vacuum-assisted biopsy needles.
• On the basis of guidance technique, the smart biopsy devices market is segmented into ultrasound-guided biopsy, stereotactic-guided biopsy, magnetic resonance imaging-guided biopsy, and other guidance techniques.
• On the basis of end user, the smart biopsy devices market is segmented into hospitals, academic and research institutes, and diagnostic and imaging centers.

Smart Biopsy Devices Market Country Level Analysis

The smart biopsy devices market is segmented on the basis of application, product, guidance technique and end-user.

The countries covered in the smart biopsy devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the smart biopsy devices market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the increase in the expenditure for research and development proficiencies and presence of major players in this region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the increasing government expenditure on healthcare sector and increasing cases of breast cancer in the region.   

The country section of the smart biopsy devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The smart biopsy devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for smart biopsy devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the smart biopsy devices market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Smart Biopsy Devices Market Share Analysis

The smart biopsy devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to smart biopsy devices market.

스마트 바이옵시 장치 시장 보고서에서 활동하는 주요 기업으로는 BD, Cook, Devicor Medical Products, Inc., ARGON MEDICAL., SOMATEX Medical Technologies GmbH, Scion Medical Technologies, LLC, UROMED Kurt Drews KG, STERYLAB Srl, DTR Medical Ltd, EndoMed Systems Alle Rechte vorbehalten., CONMED Corporation, TSK Laboratory Europe BV, ZAMAR CARE, B. Braun Melsungen AG, Cardinal Health, Siemens, General Electric Company, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Olympus Corporation, Medtronic, SRL Diagnostics 등이 있습니다.

SKU-50549